台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼1.1
  • 漲幅
    -1.39%
  • 成交量
    475
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中裕 (4147)籌碼相關-第一金-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0803/1803/2804/1004/2004/3005/1205/1460708090100110Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

第一金-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/304083.0000.0081.80401,8752.13%
2025/04/252080.0000.0080.00201,8731.07%
2025/04/241879.3800.0079.60181,8790.96%
2025/04/233080.6000.0080.60301,8791.60%
2025/04/216075.2500.0075.30601,8943.17%
2025/04/140.275.9000.0077.200.22,3750.01%
2025/04/11074.1000.0073.8002,3770.00%
2025/03/20095.80195.2095.80-12,123-0.05%
2025/03/1400.000.292.2292.50-0.22,087-0.01%
2025/03/13191.7000.0091.6012,0990.05%
2025/03/12095.9000.0097.5002,0600.00%
2025/03/100.296.7000.0097.800.22,0160.01%
2025/03/0700.00297.5096.50-21,991-0.10%
2025/03/05196.0000.0098.6011,9240.05%
2025/03/03195.9000.0094.2011,8870.05%
2025/02/2700.005197.6195.50-511,878-2.72%
2025/02/251101.0000.0099.3011,8560.05%
2025/02/2154102.90298.9098.90521,7273.01%
2025/02/1700.007100.9097.10-71,440-0.49%
2025/02/1400.00294.5098.90-21,226-0.16%
2025/02/1200.00492.2593.00-41,152-0.35%
2025/02/1000.00189.9089.90-11,129-0.09%
2025/02/06085.3000.0087.8001,1150.00%
2025/01/2000.00084.7084.2001,1360.00%
2025/01/15285.7000.0086.2021,1570.17%
2025/01/14288.5000.0087.3021,1470.17%
2025/01/13692.53393.1089.9031,1320.26%
2025/01/10387.6000.0090.5031,0640.28%
2025/01/0600.001090.1189.80-10611-1.63%
2024/12/0200.00184.8084.20-1524-0.19%
2024/11/26184.0000.0083.9015390.19%
2024/11/1400.00181.0081.00-1536-0.19%
2024/10/2800.00382.6081.00-3584-0.51%
2024/10/25381.8300.0081.4035670.53%
2024/10/01079.90079.8079.4006350.00%
2024/09/2300.00182.0080.60-1641-0.16%
2024/09/19181.0000.0080.7016480.15%
2024/09/1000.00280.6079.90-2693-0.29%
2024/08/28284.9000.0083.7027330.27%
2024/08/2000.00180.0080.00-1754-0.13%
2024/08/0800.00275.6076.70-2783-0.26%
2024/08/07275.6000.0075.6027790.26%
2024/07/30082.5000.0083.9007370.00%
2024/07/22187.50189.0087.1007450.00%
2024/07/19387.8000.0086.5037270.41%
2024/07/09385.3000.0084.1038100.37%
2024/06/2000.001389.9089.90-131,128-1.15%
2024/06/07390.1000.0090.1031,1670.26%
2024/06/06290.30189.7089.4011,1960.08%
2024/06/05890.5100.0090.3081,2370.65%
2024/05/2900.00189.8089.10-11,511-0.07%
2024/05/28188.5000.0088.7011,5550.06%
中裕首度與美國客戶簽訂CDMO合約 營運添動能Anue鉅亨-13天前
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-2025/04/09
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-2025/03/26
中裕 相關文章